iVeena Awarded $2 Million National Eye Institute Grant to Advance Novel Therapy for Pediatric Myopia
Funding will support development of a first-in-class topical eye drop designed to slow the progression of myopia in children SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company, today announced it has…